ARMCX1

gene
On this page

Also known as ALEX1GASP7

Summary

ARMCX1 (armadillo repeat containing X-linked 1, HGNC:18073) is a protein-coding gene on chromosome Xq22.1, encoding Armadillo repeat-containing X-linked protein 1 (Q9P291). Regulates mitochondrial transport during axon regeneration.

This gene encodes a member of the ALEX family of proteins and may play a role in tumor suppression. The encoded protein contains a potential N-terminal transmembrane domain and two Armadillo (arm) repeats. Other proteins containing the arm repeat are involved in development, maintenance of tissue integrity, and tumorigenesis. This gene is closely localized with other family members, including ALEX2 and ALEX3, on the X chromosome.

Source: NCBI Gene 51309 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 58 total — 3 pathogenic
  • MANE Select transcript: NM_016608

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18073
Approved symbolARMCX1
Namearmadillo repeat containing X-linked 1
LocationXq22.1
Locus typegene with protein product
StatusApproved
AliasesALEX1, GASP7
Ensembl geneENSG00000126947
Ensembl biotypeprotein_coding
OMIM300362
Entrez51309

Gene structure

Transcript identifiers

Ensembl transcripts: 31 — 31 protein_coding

ENST00000372829, ENST00000898854, ENST00000898855, ENST00000898856, ENST00000898857, ENST00000898858, ENST00000898859, ENST00000898860, ENST00000898861, ENST00000898862, ENST00000898863, ENST00000898864, ENST00000898865, ENST00000936538, ENST00000936539, ENST00000936540, ENST00000936541, ENST00000936542, ENST00000936543, ENST00000936544, ENST00000936545, ENST00000936546, ENST00000936547, ENST00000936548, ENST00000964328, ENST00000964329, ENST00000964330, ENST00000964331, ENST00000964332, ENST00000964333, ENST00000964334

RefSeq mRNA: 1 — MANE Select: NM_016608 NM_016608

CCDS: CCDS14487

Canonical transcript exons

ENST00000372829 — 4 exons

ExonStartEnd
ENSE00001032388101551569101551633
ENSE00001032390101550547101550660
ENSE00001032391101550971101551024
ENSE00001458756101552809101554700

Expression profiles

Bgee: expression breadth ubiquitous, 284 present calls, max score 98.52.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.8695 / max 240.7400, expressed in 1527 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
19696414.16801506
1969656.29251398
1969632.40891180

Top tissues by expression

286 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
germinal epithelium of ovaryUBERON:000130498.52gold quality
choroid plexus epitheliumUBERON:000391197.91gold quality
parietal pleuraUBERON:000240097.88gold quality
Brodmann (1909) area 23UBERON:001355497.37gold quality
heart right ventricleUBERON:000208096.65gold quality
pleuraUBERON:000097796.63gold quality
cartilage tissueUBERON:000241896.15gold quality
visceral pleuraUBERON:000240195.66gold quality
cauda epididymisUBERON:000436095.64gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451195.52gold quality
renal glomerulusUBERON:000007495.46gold quality
blood vessel layerUBERON:000479795.40gold quality
metanephric glomerulusUBERON:000473695.26gold quality
myocardiumUBERON:000234995.24gold quality
seminal vesicleUBERON:000099895.17gold quality
biceps brachiiUBERON:000150795.17gold quality
corpus epididymisUBERON:000435995.05gold quality
mammary ductUBERON:000176595.04gold quality
synovial jointUBERON:000221795.01gold quality
cortical plateUBERON:000534394.99gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450294.89gold quality
epithelium of mammary glandUBERON:000324494.79gold quality
hair follicleUBERON:000207394.57gold quality
middle temporal gyrusUBERON:000277194.57gold quality
amniotic fluidUBERON:000017394.52gold quality
urethraUBERON:000005794.27gold quality
cardiac muscle of right atriumUBERON:000337994.27gold quality
calcaneal tendonUBERON:000370194.27gold quality
skin of hipUBERON:000155494.23gold quality
caput epididymisUBERON:000435894.18gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-ANND-3yes10.54
E-CURD-112yes4.48

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): CREB1

miRNA regulators (miRDB)

37 targeting ARMCX1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6740-5P100.0065.64932
HSA-MIR-223-3P99.9970.141140
HSA-MIR-548C-3P99.9974.017587
HSA-LET-7C-3P99.9573.422862
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-95-5P99.8972.173973
HSA-MIR-548AZ-5P99.8369.943230
HSA-MIR-548T-5P99.8369.913220
HSA-MIR-3913-5P99.7867.26968
HSA-MIR-808499.7369.571760
HSA-MIR-120899.7068.281533
HSA-MIR-64699.6867.841645
HSA-MIR-3177-5P99.6570.381174
HSA-MIR-58699.6570.402051
HSA-MIR-885-5P99.5968.59879
HSA-MIR-4524A-5P99.5771.731193
HSA-MIR-4524B-5P99.5771.681195
HSA-MIR-312299.5066.33821
HSA-MIR-216A-5P99.5068.021288
HSA-MIR-21-5P99.4670.541035
HSA-MIR-16-2-3P99.2970.601954
HSA-MIR-195-3P99.2970.611954
HSA-MIR-590-5P99.2570.76930
HSA-MIR-607199.1667.771780
HSA-MIR-312599.1468.492269
HSA-MIR-391698.9968.042155
HSA-MIR-6859-5P98.9968.072049
HSA-MIR-4704-3P98.2869.331300
HSA-MIR-6831-5P98.2667.20990

Literature-anchored findings (GeneRIF, showing 8)

  • Human Arm protein lost in epithelial cancers, on chromosome X 1 (ALEX1) gene is transcriptionally regulated by CREB and Wnt/beta-catenin signaling. (PMID:20398052)
  • Findings suggest that overexpression of ALEX1 (armadillo repeat containing, X-linked [ARMCX]) plays a negative role in colorectal tumorigenesis. (PMID:22494058)
  • ALEX1 is a crucial tumor suppressor gene involved in cell proliferation and apoptosis in breast cancer. (PMID:25921134)
  • It is suggested that the ALEX1 protein is associated with tumorigenesis in cervical cancer and we speculate that the ALEX1 may plays a role as an oncogene in cervical cancer. (PMID:26464700)
  • ALEX1 expression is reduced in gastric cancer; ALEX1 inhibits metastasis through the PAR-1/Rho GTPase signaling pathway. (PMID:28315004)
  • Up-regulation of ALEX1 effectively rescued the cell apoptosis induced by miR-106b inhibitor and promoted the expression levels of phosphorylation of JAK1 and STAT3. (PMID:30907988)
  • ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma. (PMID:32685472)
  • The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy. (PMID:36726491)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioarmc10ENSDARG00000062960
mus_musculusArmcx1ENSMUSG00000033460
rattus_norvegicusArmcx1ENSRNOG00000046862
caenorhabditis_elegansWBGENE00013456

Paralogs (10): ARMCX3 (ENSG00000102401), ARMCX5 (ENSG00000125962), ARMC12 (ENSG00000157343), GPRASP2 (ENSG00000158301), ARMC10 (ENSG00000170632), ARMCX2 (ENSG00000184867), ARMCX4 (ENSG00000196440), GPRASP3 (ENSG00000198908), GPRASP1 (ENSG00000198932), ARMCX6 (ENSG00000198960)

Protein

Protein identifiers

Armadillo repeat-containing X-linked protein 1Q9P291 (reviewed: Q9P291)

Alternative names: ARM protein lost in epithelial cancers on chromosome X 1

All UniProt accessions (1): Q9P291

UniProt curated annotations — full annotation on UniProt →

Function. Regulates mitochondrial transport during axon regeneration. Increases the proportion of motile mitochondria by recruiting stationary mitochondria into the motile pool. Enhances mitochondria movement and neurite growth in both adult axons and embryonic neurons. Promotes neuronal survival and axon regeneration after nerve injury. May link mitochondria to the Trak1-kinesin motor complex via its interaction with MIRO1.

Subunit / interactions. Interacts with MIRO1.

Subcellular location. Mitochondrion. Mitochondrion outer membrane.

Tissue specificity. Expressed at high levels ovary, heart, testis, prostate, brain, spleen and colon. Expressed at very low levels in liver and thymus. Not expressed in peripheral blood leukocytes. Not or reduced expressed in lung, prostate, colon, pancreas and ovarian carcinomas.

Similarity. Belongs to the eutherian X-chromosome-specific Armcx family.

RefSeq proteins (1): NP_057692* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000225ArmadilloRepeat
IPR006911ARM-rpt_domDomain
IPR011989ARM-likeHomologous_superfamily
IPR016024ARM-type_foldHomologous_superfamily
IPR051303Armcx_regulatorFamily

Pfam: PF04826

UniProt features (15 total): region of interest 4, repeat 4, topological domain 2, sequence conflict 2, chain 1, compositionally biased region 1, transmembrane region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9P291-F174.280.56

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 175 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN, GOBP_AXO_DENDRITIC_TRANSPORT, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE, CHANDRAN_METASTASIS_DN, MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, AML_Q6, GOCC_MITOCHONDRIAL_ENVELOPE, DOUGLAS_BMI1_TARGETS_DN, GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS, GOCC_NEURON_PROJECTION

GO Biological Process (1): hematopoietic stem cell homeostasis (GO:0061484)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial outer membrane (GO:0005741), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
homeostasis of number of cells1
binding1
cytoplasm1
intracellular membrane-bounded organelle1
mitochondrial membrane1
organelle outer membrane1
cellular anatomical structure1

Protein interactions and networks

STRING

1059 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ARMCX1SPTAN1Q13813650
ARMCX1RHOT1Q8IXI2630
ARMCX1SNPHO15079597
ARMCX1RB1P06400549
ARMCX1TRAK2O60296548
ARMCX1GPSM1Q86YR5441
ARMCX1WDR49Q8IV35407
ARMCX1KIF5CO60282389
ARMCX1KIFC3Q9BVG8373
ARMCX1CRISPLD1Q9H336359
ARMCX1FSTL5Q8N475343
ARMCX1PLS3P13797329
ARMCX1GPSM2P81274318
ARMCX1TRAK1Q9UPV9314
ARMCX1ZBBXA8MT70312

IntAct

31 interactions, top by confidence:

ABTypeScore
ARMCX1ZBTB8Apsi-mi:“MI:0915”(physical association)0.720
ZBTB8AARMCX1psi-mi:“MI:0915”(physical association)0.720
TFIP11ARMCX1psi-mi:“MI:0915”(physical association)0.670
ARMCX1TFIP11psi-mi:“MI:0915”(physical association)0.670
ARMCX1COILpsi-mi:“MI:0915”(physical association)0.560
COILARMCX1psi-mi:“MI:0915”(physical association)0.560
GPKOWARMCX1psi-mi:“MI:0915”(physical association)0.560
PICK1ARMCX1psi-mi:“MI:0915”(physical association)0.560
CEP70ARMCX1psi-mi:“MI:0915”(physical association)0.560
BCAR1MYO1Cpsi-mi:“MI:0914”(association)0.350
FECHPOTEFpsi-mi:“MI:0914”(association)0.350
ARMCX1GYG1psi-mi:“MI:0914”(association)0.350
LGALS3BPACACBpsi-mi:“MI:0914”(association)0.350
PPARDLRP6psi-mi:“MI:0914”(association)0.350
GATA2C11orf98psi-mi:“MI:0914”(association)0.350
CDH5ESYT2psi-mi:“MI:2364”(proximity)0.270
ARMCX1ZBTB8Apsi-mi:“MI:0915”(physical association)0.000
ARMCX1PICK1psi-mi:“MI:0915”(physical association)0.000
ARMCX1CEP70psi-mi:“MI:0915”(physical association)0.000
ARMCX1psi-mi:“MI:0915”(physical association)0.000

BioGRID (15): ARMCX1 (Two-hybrid), ARMCX1 (Two-hybrid), ZBTB8A (Two-hybrid), ARMCX1 (Affinity Capture-MS), ARMCX1 (Affinity Capture-MS), ARMCX1 (Affinity Capture-MS), ARMCX1 (Affinity Capture-MS), ARMCX1 (Positive Genetic), ARMCX1 (Two-hybrid), ARMCX1 (Two-hybrid), ARMCX1 (Two-hybrid), ZBTB8A (Two-hybrid), ARMCX1 (Affinity Capture-MS), SPC25 (Cross-Linking-MS (XL-MS)), ARMCX1 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A0M3U1B0, A1A5Q6, A2AFS9, A2AVR2, A2CI98, A2CJ06, A2RTY3, A2RUW0, O70167, O70173, P0C2Y1, P15304, P59729, Q08EC4, Q3SYK4, Q3TYG6, Q3U1D0, Q4R744, Q4R9E9, Q5R4B2, Q5T4T6, Q5TGP6, Q5VWK0, Q68CQ1, Q6AYJ3, Q6IFT4, Q6IRU7, Q6REY9, Q6ZUA9, Q7Z572, Q80VH0, Q86WZ0, Q86XG9, Q8C0X8, Q8CCC3, Q8ND61, Q8NDZ2, Q8TB24, Q96M43, Q96QP1

Diamond homologs: B1WBW4, Q3UZB0, Q5H9R4, Q5JY77, Q5R4B2, Q5R7U0, Q5R9J3, Q5RDG2, Q5U310, Q5U4C1, Q5XID7, Q6A058, Q6P1M9, Q6PI77, Q7L311, Q8BHS6, Q8BUY8, Q8N2F6, Q920R4, Q96D09, Q9BE11, Q9CX83, Q9D0L7, Q9P291, Q9UH62, Q6PB60, Q71HP2, Q66HF0, Q7L4S7, Q8K3A6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

58 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic3
Likely pathogenic0
Uncertain significance32
Likely benign3
Benign1

Top pathogenic / likely-pathogenic (3)

Variant IDHGVSClassification
3024654GRCh37/hg19 Xq12-28(chrX:67292994-155240074)x3Pathogenic
57972GRCh38/hg38 Xq22.1(chrX:101323599-101596196)x1Pathogenic
57973GRCh38/hg38 Xq22.1-22.3(chrX:101407698-106274188)x1Pathogenic

SpliceAI

796 predictions. Top by Δscore:

VariantEffectΔscore
X:101551634:G:GGdonor_gain1.0000
X:101550657:GCAG:Gdonor_gain0.9800
X:101550969:A:AGacceptor_gain0.9800
X:101550969:AGTAG:Aacceptor_gain0.9800
X:101550970:G:GGacceptor_gain0.9800
X:101550970:GTA:Gacceptor_gain0.9800
X:101550970:GTAGG:Gacceptor_gain0.9800
X:101552548:G:GTdonor_gain0.9800
X:101552803:TCCTA:Tacceptor_loss0.9800
X:101552804:CCTA:Cacceptor_loss0.9800
X:101552805:CTAGG:Cacceptor_loss0.9800
X:101552806:TA:Tacceptor_loss0.9800
X:101552807:A:ACacceptor_loss0.9800
X:101552808:G:Aacceptor_loss0.9800
X:101550656:AGCAG:Adonor_loss0.9700
X:101550657:GCAGG:Gdonor_loss0.9700
X:101550658:CAGG:Cdonor_loss0.9700
X:101550659:AG:Adonor_loss0.9700
X:101550660:G:GCdonor_loss0.9700
X:101550661:G:Adonor_loss0.9700
X:101550662:T:Gdonor_loss0.9700
X:101550730:G:GTdonor_gain0.9700
X:101550970:GT:Gacceptor_gain0.9700
X:101551156:G:GTdonor_gain0.9700
X:101551634:GTA:Gdonor_loss0.9700
X:101551635:TAG:Tdonor_loss0.9700
X:101553057:GAGTC:Gdonor_gain0.9700
X:101551021:GCAGG:Gdonor_loss0.9600
X:101551022:CAG:Cdonor_loss0.9600
X:101551023:AGG:Adonor_loss0.9600

AlphaMissense

2968 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:101553753:A:CS275R1.000
X:101553755:T:AS275R1.000
X:101553755:T:GS275R1.000
X:101553852:G:TG308W1.000
X:101553550:T:CL207P0.999
X:101553571:T:CL214P0.999
X:101553607:C:AA226D0.999
X:101553610:T:GL227W0.999
X:101553619:T:CL230P0.999
X:101553622:G:AG231D0.999
X:101553630:G:CA234P0.999
X:101553631:C:AA234E0.999
X:101553658:T:AI243K0.999
X:101553658:T:GI243R0.999
X:101553661:G:CR244P0.999
X:101553738:G:CA270P0.999
X:101553742:T:AL271H0.999
X:101553742:T:CL271P0.999
X:101553746:T:AN272K0.999
X:101553746:T:GN272K0.999
X:101553749:C:AN273K0.999
X:101553749:C:GN273K0.999
X:101553751:T:CL274S0.999
X:101553770:T:AN280K0.999
X:101553770:T:GN280K0.999
X:101553852:G:AG308R0.999
X:101553852:G:CG308R0.999
X:101553856:T:CL309P0.999
X:101553862:T:CL311P0.999
X:101553872:C:AN314K0.999

dbSNP variants (sampled 300 via entrez): RS1000683827 (X:101552196 A>G), RS1000709469 (X:101554625 A>G), RS1001011875 (X:101552493 A>C), RS1001442610 (X:101554230 C>T), RS1001512758 (X:101553492 C>T), RS1001846295 (X:101551290 G>C), RS1003447312 (X:101549895 A>G), RS1005199331 (X:101552999 T>C), RS1006801754 (X:101551244 T>C), RS1007632718 (X:101550435 G>C), RS1010907360 (X:101549937 G>C), RS1011399911 (X:101549388 T>C), RS1016586231 (X:101550633 G>A), RS1017345805 (X:101552508 G>T), RS1019022758 (X:101550436 G>A)

Disease associations

OMIM: gene MIM:300362 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

44 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression, increases expression4
sodium arsenitedecreases expression, affects methylation3
Silicon Dioxideincreases expression3
bisphenol Aincreases expression, affects cotreatment2
Indomethacindecreases expression, affects cotreatment, increases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Cyclosporinedecreases expression, increases expression2
Particulate Matterincreases abundance, affects cotreatment, decreases expression2
aristolochic acid Iincreases expression1
TAK-243increases sumoylation1
dodecyldimethylamine oxideincreases expression1
arseniteincreases methylation1
butyraldehydeincreases expression1
zinc chromateincreases abundance, increases expression1
nickel sulfatedecreases expression1
chromium hexavalent ionincreases abundance, increases expression1
perfluorooctane sulfonic acidincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamidedecreases expression, affects cotreatment1
nutlin 3affects cotreatment, increases expression1
abrineincreases expression1
dorsomorphinaffects cotreatment, decreases expression1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidineincreases response to substance, increases expression1
Temozolomidedecreases expression1
Sunitinibdecreases expression1
Acetaminophenincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Ethanolaffects cotreatment, decreases expression, increases abundance1
Benzo(a)pyreneaffects methylation, decreases methylation1
Camptothecinincreases expression1
Dactinomycinaffects cotreatment, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.